1Lee JY, Yang CC, Chao SC, et al. Histopathological differential diagnosis of keloid and hypertrophic scar [ J ]. Am J Dermato- pathol, 2004,26(5) :379-384.
2Garcla-Ulloa AC, Arrieta O. Tubal occlusion causing infertility due to an excessive inilammatory response in patients with predisposition for keloid formation[ J]. Med Hypotheses, 2005,65(5) :908-914.
4Zlotnik A, Yoshie O, Nomiyama H. The chemokine and chemo- kine receptor superfamilies and their molecular evolufion[ J ]. Ge- home Biol, 2006,7(12) :243.
5Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry [ J ]. Circ Res, 2003,92 (8) :827-839.
6Goede V, Brogelli L, Ziche M, et al. Induction of inflanunatory angiogenesis by monocyte chemoattractant protein-1 [ J ]. Int J Cancer, 1999,82(5) :765-770.
7Xia Y, Frangogiannis NG. MCP-1/CCL2 as a therapeutic target in myocardial infarction and ischemic cardiomyopathy [ J ]. Inflamm Allergy Drug Targets, 2007,6(2) :101-107.
8Tesch GH. MCP-1/CCL2: a new diagnostic marker and therapeu- tic target for progressive renal injury in diabetic nephropathy [ J ]. Am J Physiol Renal Physiol, 2008,294(4) : 697-701.
9Marra F. Renaming cytokines: MCP-I, major chemokine in pan- creatitis[ J ]. Gut, 2005,54 (12) : 1679-1681.
10Gharaee-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor betal gene ex- pression by monocyte chemoattractant protein-1 via special recep- tors[J]. J Biol Chem, 1996,271 (30) :17779-17784.
